The Prostate Net
 
About Us
Store
In the Know Awards
Barbershop Initiative®
Programs
Press & News
DONATE
Locate a Physician
Podcast
Patient Support
Treatment Options
The Knowledge Net
Newsletter
Contact Us

 

The Prostate Net®Inc.
P. O. Box 10188-#77550
Newark, NJ 07101-3188
Tel: 1.201.289.8221
Fax: 1.270.294.1565

support@prostatenet.org

This website is certified by Health On the Net Foundation. Click to verify.

This page was
 

Targeted Therapies

Chemotherapy, like radiation, does not distinguish between healthy cells and cancer cells in the cytotoxic process with sometimes resulting side effects. This has caused researchers to focus on the development of therapies that address specific cellular or systemic approaches to better target the cancer.

Some examples of these new protocols are:

Vaccine Therapy - a mechanism for altering the patient's immune system to make it better able to fight the cancer; one example is Provenge, details of which can be viewed at www.dendreon.com. Additional information can be gained from the interview with one of the drug's principal investigator's that can be viewed here

Endothelin blocker - a drug that blocks a protein called endothelin, that is thought to help spread cancer cells, has been shown to improve quality of life by delaying the onset of bone pain and disease progression.

Clinical trials on these and other new protocols can be found through listings on the sites noted on the Clinical Trials page.

 

 

 

Go to:

Alternative Medicine

Chemotherapy

Clinical Trials

Cytotoxic Therapy

Diagnostics

Hormones

Informed Decision Making

Pain Management

Palliative Care

Radiation Solutions

Dealing with Side Effects

Surgical Solutions

Targeted Therapies

Translational Research

Active Surveillance

For Email Newsletters you can trust

 

Home | About Us | Store | In the Know Newsletter | Barbershop Initiative | Programs | Press & News | DONATE | Locate a Physician | Podcast | Treatments Options | The Knowledge Net | Contact Us

Site Designed by:
Marshall Haber Creative Group inc.